These data, along with other studies, suggest that IL-1 via IL-1R1 receptor accounts for the expression of IL-22, which acts on intestinal barrier function and control of HFD diet-induced obesity. Here, IL22 is linked to obesity due to melanocortin 4 receptor deficiency.